FDA Officials Detail Plan to Limit COVID Shots

(MedPage Today) -- FDA officials have outlined their new approach to COVID-19 vaccine approvals, allowing immunogenicity endpoints for high-risk groups, while calling for randomized controlled trials for those at lower risk.
FDA Commissioner Marty...